| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|
| Period End Date | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 |
|---|
| Revenues | 1,656.60 | 1,557.40 | 1,493.10 | 1,424.90 | 1,327.58 | 1,265.05 | 1,231.66 | 1,214.97 | 1,165.10 | 1,142.17 |
| Total Revenues | 1,656.60 | 1,557.40 | 1,493.10 | 1,424.90 | 1,327.58 | 1,265.05 | 1,231.66 | 1,214.97 | 1,165.10 | 1,142.17 |
| Cost of revenues | 196.30 | 191.40 | 197.30 | 200.70 | 191.93 | 180.18 | 180.47 | 192.13 | 193.33 | 198.24 |
| Gross Profit | 1,460.30 | 1,366.00 | 1,295.80 | 1,224.20 | 1,135.64 | 1,084.88 | 1,051.19 | 1,022.84 | 971.77 | 943.93 |
| Impairment of goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization of other intangible assets and write-down of goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization and impairment of goodwill and other intangible assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development expenses | 103.60 | 96.70 | 91.00 | 85.70 | 80.53 | 74.67 | 60.81 | 57.88 | 52.34 | 59.10 |
| Acquired in-process research and development | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| General and Administrative | 235.70 | 211.10 | 204.20 | -- | 148.43 | 149.21 | 137.63 | 132.67 | 129.75 | 118.00 |
| Sales and marketing | -- | -- | -- | 195.40 | 39.88 | 36.79 | 46.64 | 64.89 | 81.95 | 80.25 |
| Restructuring, impairments and other (charges) reversals | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | 535.60 | 499.20 | 492.50 | 481.80 | 460.77 | 440.85 | 425.53 | 447.58 | 457.37 | 455.60 |
| Operating Income / (Loss) | 1,121.00 | 1,058.20 | 1,000.60 | 943.10 | 866.80 | 824.20 | 806.13 | 767.39 | 707.72 | 686.57 |
| Interest expense | 77.00 | 75.30 | 75.30 | 75.30 | 83.26 | 90.14 | 90.61 | 114.85 | 136.34 | 115.56 |
| Gain on sale of VeriSign Japan stock | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Minority interest | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest and investment income (loss) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other income (expense), net | 24.50 | 39.00 | 51.20 | 12.40 | (1.33) | 16.19 | 43.26 | 76.97 | 27.63 | 10.17 |
| Sale of business and litigation settlements | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income (loss) before income taxes | 1,068.50 | 1,021.90 | 976.50 | 880.20 | 782.22 | 750.24 | 758.78 | 729.52 | 599.01 | 581.17 |
| Current-State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred- Foreign | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred:Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred:State | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income tax expense (benefit) | 242.80 | 236.20 | 158.90 | 206.40 | (2.61) | (64.64) | 146.48 | 147.03 | 141.76 | 140.53 |
| Current-Federal | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Current:Foreign, including foreign withholding tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Charge in lieu of taxes attributable to employee stock option plans | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Charge in lieu of taxes resulting from initial recognition of acquired tax benef | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Minority interest, net of tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings from unconsolidated entities, net of tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income from Continuing Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on sale of discontinued operations, net of tax | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income (loss) from discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Consolidated Net Income (Loss) | 825.70 | 785.70 | 817.60 | -- | -- | -- | 612.30 | 582.49 | 457.25 | -- |
| Less: Net income attributable to noncontrolling interest in subsidiary | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Income (Loss) Available to Common Shareholders | 825.70 | 785.70 | 817.60 | 673.80 | 784.83 | 814.89 | 612.30 | 582.49 | 457.25 | 440.65 |
| EPS (Basic) - Cont Ops | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Basic) - Disc Ops | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Basic) | 8.83 | 8.01 | 7.91 | 6.24 | 7.01 | 7.08 | 5.17 | 5.13 | 4.56 | 4.12 |
| EPS (Diluted) - Cont Ops | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Diluted) - Disc Ops | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net Earnings Per Share (Diluted) | 8.81 | 8.00 | 7.90 | 6.24 | 7.00 | 7.07 | 5.15 | 4.75 | 3.68 | 3.42 |
| Weighted Average Shares Outstanding (Basic) | 93.50 | 98.10 | 103.40 | 107.90 | 112.02 | 115.06 | 118.51 | 113.45 | 100.33 | 107.00 |
| Weighted Average Shares Outstanding (Diluted) | 93.80 | 98.20 | 103.50 | 108.00 | 112.17 | 115.30 | 118.97 | 122.66 | 124.18 | 128.83 |